3.4.22.B62	(2E)-2-[(2,3-dimethyl-1,4-dioxidoquinoxalin-6-yl)methylidene]-N-(2-phenylethyl)hydrazinecarboxamide	32% inhibiton at 0.01 mM	237614	
3.4.22.B62	(2E)-2-[(2-amino-3-cyano-1,4-dioxidoquinoxalin-6-yl)methylidene]-N-(2-phenylethyl)hydrazinecarboxamide	61% inhibiton at 0.01 mM	237615	
3.4.22.B62	(2E)-2-[(2-amino-3-cyano-1,4-dioxidoquinoxalin-6-yl)methylidene]-N-(prop-2-en-1-yl)hydrazinecarbothioamide	39% inhibiton at 0.01 mM	237616	
3.4.22.B62	(2E)-2-[(2-amino-3-cyano-1,4-dioxidoquinoxalin-6-yl)methylidene]-N-butylhydrazinecarboxamide	27% inhibiton at 0.01 mM	237617	
3.4.22.B62	(2E)-N'-(2-[(naphthalen-1-ylmethyl)sulfanyl]acetyl)-3-phenylprop-2-enehydrazide	-	239815	
3.4.22.B62	(2Z)-2-[(2E)-[(2,3-dimethyl-1,4-dioxidoquinoxalin-6-yl)methylidene]hydrazinylidene]-3-(prop-2-en-1-yl)-1,3-thiazolidin-4-one	22% inhibiton at 0.01 mM	237817	
3.4.22.B62	(6,7-difluoro-3-methyl-1,4-dioxidoquinoxalin-2-yl)(phenyl)methanone	17% inhibiton at 0.01 mM	237958	
3.4.22.B62	2-([4-benzyl-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl]sulfanyl)-1-(1,2,3,4-tetrahydroquinolin-1-yl)ethan-1-one	-	239814	
3.4.22.B62	2-methylquinoxaline 1,4-dioxide	8% inhibiton at 0.01 mM	238201	
3.4.22.B62	3-amino-7-([ethyl[(2Z)-3-phenylprop-2-en-1-yl]amino]methyl)quinoxaline-2-carbonitrile 1,4-dioxide	45% inhibiton at 0.01 mM	238319